What is BioIntelliSense worth?
$1.2Blast known valuation
BioIntelliSense last raised $58.3M in its Later Stage VC (Dec 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for BioIntelliSense
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Later Stage VC | $58.3M | ▮ | ▮ |
| Apr 2021 | Early Stage VC | $45.0M | ▮ | ▮ |
| Aug 2020 | Early Stage VC | $12.0M | ▮ | ▮ |
| Dec 2018 | Early Stage VC | $25.0M | ▮ | ▮ |
How BioIntelliSense's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For BioIntelliSense, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is BioIntelliSense worth?
- BioIntelliSense's last known valuation is $1.2B.
- How much has BioIntelliSense raised?
- BioIntelliSense has raised $318.6M in total funding across 4 recorded rounds.
- When did BioIntelliSense last raise?
- BioIntelliSense last raised in Dec 2025 (Later Stage VC), raising $58.3M.